Improving statistics to better understand Alzheimer's disease

Statistical Methods for Alzheimer's Research

NIH-funded research University of California-Irvine · NIH-11297533

This project builds new statistical tools to help researchers track Alzheimer’s risk, timing, and repeated health events in older adults, including people from underrepresented groups.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California-Irvine NIH-funded
Lab location1 site (Irvine, United States)
Project IDNIH-11297533 on NIH RePORTER

What this research studies

From a patient's point of view, the team is creating better mathematical methods to make sense of data from long-term aging studies so we can know when Alzheimer’s might start and how often related health events happen. They are handling common problems like missing or partly known information, repeated hospital visits or symptoms, and the fact that death can stop follow-up. The researchers will also make user-friendly software so other scientists can use the methods. The work focuses on U.S. aging groups and pays special attention to people who are often underrepresented in research.

Who could benefit from this research

Good fit: Ideal candidates for related data collection are older adults at risk for Alzheimer's or living with early signs of cognitive decline, particularly those enrolled in long-term aging cohort studies and including people from underrepresented backgrounds.

Not a fit: People without ties to aging or Alzheimer's cohort studies, or those with conditions unrelated to Alzheimer's disease, are unlikely to see direct benefits from this work.

Why it matters

Potential benefit: If successful, these methods could lead to more accurate prediction of Alzheimer's onset and better-designed studies and care plans for older adults, especially those from underrepresented communities.

How similar studies have performed: Existing statistical approaches for single-time survival events have been used successfully, but extending these methods to recurrent events and partially observed risk sets is newer and less tested.

Where this research is happening

Irvine, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.